https://www.vanlanschotkempen.com/en-nl/investment-banking/equities/life-sciences-and-healthcare/life-sciences-conference
Idiopathic Pulmonary Fibrosis: 5 Things to Know
MedNous article: A surprise finding in the clinic
Vicore’s ATTRACT study shows promise for novel drug C21 against COVID-19 in hospitalised patients
Patient insights to shape development of a dCBT for IPF patients
Idiopathic Pulmonary Fibrosis (IPF) – weathering the pandemic